SEARCH

SEARCH BY CITATION

References

  • Abebe W, Mustafa SJ (1998). A1 adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle. Am J Physiol 275: L990L997.
  • Allen-Gipson DS, Wong J, Spurzem JR, Sisson JH, Wyatt TA (2006). Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L849L855.
  • Ball HA, Van Scott MR, Robinson CB (2004). Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders. Clin Rev Allergy Immunol 27: 207217.
  • Barnes PJ (2006). Drugs for asthma. Br J Pharmacol 147: S297S303.
  • Bjorck T, Gustafsson LE, Dahlen SE (1992). Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 145: 10871091.
  • Blackburn MR, Kellems RE (2005). Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 86: 141.
  • Blackburn MR, Volmer JB, Thrasher JL, Zhong H, Crosby JR, Lee JJ et al. (2000). Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 192: 159170.
  • Bouma MG, Jeunhomme TM, Boyle DL, Dentener MA, Voitenok NN, van den Wildenberg FA et al. (1997). Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol 158: 54005408.
  • Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA (1994). Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153: 41594168.
  • Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC (2006). Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112: 358404.
  • Brown RA, Clarke GW, Ledbetter CL, Hurle MJ, Denyer JC, Simcock DE et al. (2008). Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J 31: 19.
  • Burnstock G (2006). Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27: 166176.
  • Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988). Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12: 345355.
  • Carbajal V, Vargas MH, Flores-Soto E, Martínez-Cordero E, Bazán-Perkins B, Montaño LM (2005). LTD4 induces hyperresponsiveness to histamine in bovine airway smooth muscle: role of SR-ATPase Ca2+ pump and tyrosine kinase. Am J Physiol Lung Cell Mol Physiol 288: L84L92.
  • Cass CE, Young JD, Baldwin SA (1998). Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol 76: 761770.
  • Chunn JL, Young HWJ, Banerjee SK, Colasurdo GN, Blackburn MR (2001). Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 167: 46764685.
  • Clarke H, Cushley MJ, Persson CG, Holgate ST (1989). The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5′-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol 2: 147154.
  • Crimi E, Brusasco V, Brancatisano M, Losurdo E, Crimi P (1986). Adenosine-induced bronchoconstriction: premedication with chlorpheniramine and nedocromil sodium. Eur J Respir Dis Suppl 147: 255257.
  • Crimi N, Palermo F, Oliveri R, Vancheri C, Polosa R, Palermo B et al. (1988). Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects. Clin Allergy 18: 367374.
  • Crimi N, Palermo F, Polosa R, Oliveri R, Maccarrone C, Palermo B et al. (1989). Effect of indomethacin on adenosine-induced bronchoconstriction. J Allergy Clin Immunol 83: 921925.
  • Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M (1990). The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 85: 11501157.
  • Cronstein BN, Kubersky SM, Weissmann G, Hirschhorn R (1987). Engagement of adenosine receptors inhibits hydrogen peroxide (H2O2-) release by activated human neutrophils. Clin Immunol Immunopathol 42: 7685.
  • Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G (1992). Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148: 22012206.
  • Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R (1985). Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 135: 13661371.
  • Csoma Z, Huszar E, Vizi E, Vass G, Szabo Z, Herjavecz I et al. (2005). Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 25: 873878.
  • Cushley MJ, Tattersfield AE, Holgate ST (1983). Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15: 161165.
  • Dekhuijzen PN, Koopmans PP (2002). Pharmacokinetic profile of zafirlukast. Clin Pharmacokinet 41: 105114.
  • Driver AG, Kukoly CA, Ali S, Mustafa SJ (1993). Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 9197.
  • Ellis JL, Undem BJ (1994). Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi. Am J Respir Crit Care Med 149: 118122.
  • Ethier MF, Madison JM (2006). Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells. Am J Respir Cell Mol Biol 35: 496502.
  • Ezeamuzie CI, Philips E (1999). Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol 127: 188194.
  • Ezeamuzie CI, Philips E (2003). Positive coupling of atypical adenosine A3 receptors on human eosinophils to adenylyl cyclase. Biochem Biophys Res Commun 300: 712718.
  • Fan M, Qin W, Mustafa SJ (2003). Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model. Am J Physiol Lung Cell Mol Physiol 284: L1012L1019.
  • Felsch A, Stocker K, Borchard U (1995). Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists. J Immunol 155: 333338.
  • Feoktistov I, Biaggioni I (1995). Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96: 19791986.
  • Forsythe P, Ennis M (1999). Adenosine, mast cells and asthma. Inflamm Res 48: 301307.
  • Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M (1999). Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci (Lond) 96: 349355.
  • Fozard JR, Baur F, Wolber C (2003). Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog. Eur J Pharmacol 475: 7984.
  • Fozard JR, Ellis KM, Villela Dantas MF, Tigani B, Mazzoni L (2002). Effects of CGS21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 438: 183188.
  • Fredholm BB, Ijzerman AP, Jacobso KA, Klotz KN, Linden J (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527552.
  • Fredholm BB, Zhang Y, van der Ploeg I (1996). Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedebergs Arch Pharmacol 354: 262267.
  • Hakonarson H, Shanbaky I, Guerra FM, Grunstein MM (1998). Modulation of adenosine A1, bradykinin B1, and histamine H1 receptor expression and function in atopic asthmatic sensitized airway smooth muscle. Am J Respir Crit Care Med Abstracts issue, C56.
  • Hannon JP, Bray-French KM, Phillips RM, Fozard JR (1998). Further pharmacological characterization of the adenosine receptor subtype mediating inhibition of oxidative burst in human isolated neutrophils. Drug Dev Res 43: 214224.
  • Hasko G, Pacher P, Deitch EA, Vizi ES (2007). Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 113: 264275.
  • Holgate ST (2005). The identification of the adenosine A2B receptor as a novel therapeutic target in asthma. Br J Pharmacol 145: 10091015.
  • Hua X, Erikson CJ, Chason KD, Rosebrock CN, Deshpande DA, Penn RB et al. (2007). Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice. Am J Physiol Lung Cell Mol Physiol 293: L25L32.
  • Huang S, Apasov S, Koshiba M, Sitkovsky M (1997). Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 16001610.
  • Hughes PJ, Holgate ST, Church MK (1984). Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol 33: 38473852.
  • Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar Vilagos G et al. (2002). Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 20: 13931398.
  • Jacques CA, Spur BW, Johnson M, Lee TH (1991). The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro. Br J Pharmacol 104: 859866.
  • Jacques CA, Spur BW, Johnson M, Lee TH (1992). The effect of epithelium removal on leukotriene E4-induced histamine hyperresponsiveness in guinea-pig tracheal smooth muscle. Br J Pharmacol 106: 556562.
  • Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ (1999). Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160 (5 Part 1): 15321539.
  • Joad JP (1990). Characterization of the human peripheral lung adenosine receptor. Am J Respir Cell Mol Biol 2: 193198.
  • Johnson HG, McNee ML (1985). Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives. Br J Pharmacol 86: 6367.
  • Keir S, Boswell-Smith V, Spina D, Page C (2006). Mechanism of adenosine-induced airways obstruction in allergic guinea pigs. Br J Pharmacol 147: 720728.
  • Knight D, Zheng X, Rocchini C, Jacobson M, Bai T, Walker B (1997). Adenosine A3 receptor stimulation inhibits migration of human eosinophils. J Leukoc Biol 62: 465468.
  • Lappas CM, Sullivan GW, Linden J (2005). Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs 14: 797806.
  • Lee TH, Austen KF, Corey EJ, Drazen JM (1984). Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci USA 81: 49224925.
  • Lever R, Hefni A, Moffatt JD, Paul W, Page CP (2007). Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses. Clin Exp Allergy 37: 909917.
  • Liesker JJ, Ten Hacken NH, Rutgers SR, Zeinstra-Smith M, Postma DS, Timens W (2007). Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD. Respir Med 101: 882887.
  • Luijk B, van den Berge M, Kerstjens A, Postma DD, Lammers JWJ (2003). Effect of an inhaled adenosine A2A agonist on the allergen induced late asthmatic response. Eur Respir J 22 (Suppl. 45): 204s.
  • Mann JS, Holgate ST, Renwick AG, Cushley MJ (1986). Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 61: 16671676.
  • Marquardt DL, Parker CW, Sullivan TJ (1978). Potentiation of mast cell mediator release by adenosine. J Immunol 120: 871878.
  • Marquardt DL, Walker LL, Wasserman SI (1984). Adenosine receptors on mouse bone marrow-derived mast cells: functional significance and regulation by aminophylline. J Immunol 133: 932937.
  • McNamara N, Gallup M, Khong A, Sucher A, Maltseva I, Fahy J et al. (2004). Adenosine up-regulation of the mucin gene, MUC2, in asthma. FASEB J 18: 17701772.
  • Mubagwa K, Mullane K, Flameng W (1996). Role of adenosine in the heart and circulation. Cardiovasc Res 32: 797813.
  • Mustafa SJ, Nadeem A, Fan M, Zhong H, Belardinelli L, Zeng D (2007). Effect of a specific and selective A2B adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 320: 12461251.
  • Nadeem A, Fan M, Ansari HR, Ledent C, Jamal Mustafa S (2007). Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice. Am J Physiol Lung Cell Mol Physiol 292: L1335L1344.
  • Nadeem A, Obiefuna PC, Wilson CN, Mustafa SJ (2006). Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation. Eur J Pharmacol 551: 116124.
  • Nelson HS (2003). Prospects for antihistamines in the treatment of asthma. J Allergy Clin Immunol 112 (Suppl. 4): S96S100.
  • Newby AC (1984). Adenosine and the concept of retaliatory metabolites. Trends Biochem Sci 9: 4244.
  • Nightingale JA, Rogers DF, Barnes PJ (1999). Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. Am J Respir Crit Care Med 159: 17861790.
  • Nyce JW (1999). Insight into adenosine receptor function using antisense and gene-knockout approaches. Trends Pharmacol Sci 20: 7983.
  • Nyce JW, Metzger WJ (1997). DNA antisense therapy for asthma in an animal model. Nature 385: 721725.
  • O'Connor BJ, Chung KF, Chen-Worsdell YM, Fuller RW, Barnes PJ (1991). Effect of inhaled furosemide and bumetanide on adenosine 5′-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 143: 13291333.
  • Obiefuna PC, Batra VK, Nadeem A, Borron P, Wilson CN, Mustafa SJ (2005). A novel A1 adenosine receptor antagonist (L-97-1) reduces allergic responses to house dust mite in an allergic rabbit model of asthma. J Pharmacol Exp Ther 315: 329336.
  • Panther E, Idzko M, Herouy Y, Rheinen H, Gebicke-Haerter PJ, Mrowietz U et al. (2001). Expression and function of adenosine receptors in human dendritic cells. FASEB J 15: 19631970.
  • Pascoe SJ, Knight H, Woessner R (2007). QAF805, an A2B/A3 antagonist, does not attenuate AMP challenge in subjects with asthma. Proceedings of the American Thoracic Society A682.
  • Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G (1988). Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 138: 11431151.
  • Peachell PT, Lichtenstein LM, Schleimer RP (1991). Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256: 717726.
  • Phillips GD, Finnerty JP, Holgate ST (1990). Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5′-monophosphate in asthma. J Allergy Clin Immunol 85: 755762.
  • Phillips GD, Holgate ST (1989). The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in nonatopic asthma. Am Rev Respir Dis 139: 463469.
  • Phillips GD, Rafferty P, Beasley R, Holgate ST (1987). Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax 42: 939945.
  • Phillips GD, Scott VL, Richards R, Holgate ST (1989). Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 2: 210217.
  • Polosa R, Ng WH, Crimi N, Vancheri C, Holgate ST, Church MK et al. (1995). Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 151 (3 Part 1): 624629.
  • Polosa R, Phillips GD, Rajakulasingam K, Holgate ST (1991). The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma. J Allergy Clin Immunol 87: 939947.
  • Polosa R, Rajakulasingam K, Church MK, Holgate ST (1992). Repeated inhalation of bradykinin attenuates adenosine 5′-monophosphate (AMP) induced bronchoconstriction in asthmatic airways. Eur Respir J 5: 700706.
  • Polosa R, Rajakulasingam K, Prosperini G, Church MK, Holgate ST (1993). Relative potencies and time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled furosemide and bumetanide in asthma. J Allergy Clin Immunol 92: 288297.
  • Polosa R, Santonocito G, Magrì S, Paolino G, Armato F, Pagano C et al. (1997). Neutral endopeptidase inhibition with inhaled phosphoramidon: no effect on bronchial responsiveness to adenosine 5′-monophosphate (AMP) in asthma. Eur Respir J 10: 24602464.
  • Rafferty P, Beasley R, Holgate ST (1987a). The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′ monophosphate in atopic asthma. Am Rev Respir Dis 136: 369373.
  • Rafferty P, Beasley R, Southgate P, Holgate S (1987b). The role of histamine in allergen and adenosine-induced bronchoconstriction. Int Arch Allergy Appl Immunol 82: 292294.
  • Ralevic V, Burnstock G (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50: 413492.
  • Ramkumar V, Stiles GL, Beaven MA, Ali H (1993). The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268: 1688716890.
  • Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Kundu S et al. (1997). Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 52: 4548.
  • Riffo-Vasquez Y, Spina D, Page C, Tormay P, Singh M, Henderson B et al. (2004). Effect of mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin Exp Allergy 34: 712719.
  • Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST (2002). Role of cysteinyl leukotrienes in adenosine 5′-monophosphate induced bronchoconstriction in asthma. Thorax 57: 323327.
  • Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I (2004). Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 172: 77267733.
  • Salmon JE, Brogle N, Brownlie C, Edberg JC, Kimberly RP, Chen BX et al. (1993). Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function. J Immunol 151: 27752785.
  • Spicuzza L, Di Maria G, Polosa R (2006). Adenosine in the airways: implications and applications. Eur J Pharmacol 533: 7788.
  • Spicuzza L, Polosa R (2003). The role of adenosine as a novel bronchoprovocant in asthma. Curr Opin Allergy Clin Immunol 3: 6569.
  • Spruntulis LM, Broadley KJ (2001). A3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs. Clin Exp Allergy 31: 943951.
  • Sullivan AK, Uhlson CL, Murphy RC, Voelkel NP (2005). Elevated adenosine in the exhaled air of patients with COPD. Am J Respir Crit Care Med Abstracts issue, A653.
  • Summers QA, Honeywell R, Renwick AG, Holgate ST (1990). The protective efficacy of inhaled, oral and intravenous nedocromil sodium against adenosine-5′-monophosphate-induced bronchoconstriction in asthmatic volunteers. Pulm Pharmacol 3: 190197.
  • Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR (2005). A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 115: 3543.
  • Suzuki H, Takei M, Nakahata T, Fukamachi H (1998). Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. Biochem Biophys Res Commun 242: 697702.
  • Tilley SL, Tsai M, Williams CM, Wang ZS, Erikson CJ, Galli SJ et al. (2003). Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice. J Immunol 171: 331337.
  • van den Berge M, Kerstjens HA, de Reus DM, Koeter GH, Kauffman HF, Postma DS (2004). Provocation with adenosine 5′-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 34: 7176.
  • Varani K, Caramori G, Vincenzi F, Adcock I, Casolari P, Leung E et al. (2006). Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 398406.
  • Vizi E, Huszar E, Csoma Z, Boszormenyi-Nagy G, Barat E, Horvath I et al. (2002). Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol 109: 446448.
  • Walker BA, Jacobson MA, Knight DA, Salvatore CA, Weir T, Zhou D et al. (1997). Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 16: 531537.
  • Walsh GM (2002). Second-generation antihistamines in asthma therapy: is there a protective effect Am J Respir Med 1: 2734.
  • Wilson CN, Batra VK (2002). Lipopolysaccharide binds to and activates A1 adenosine receptors on human pulmonary artery endothelial cells. J Endotoxin Res 8: 263271.
  • Wollner A, Wollner S, Smith JB (1993). Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils. Am J Respir Cell Mol Biol 9: 179185.
  • Wood-Baker R, Holgate ST (1993). The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol 91: 10051014.
  • Young HW, Molina JG, Dimina D, Zhong H, Jacobson M, Chan LN et al. (2004). A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173: 13801389.
  • Zhang JG, Hepburn L, Cruz G, Borman RA, Clark KL (2005). The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. Biochem Pharmacol 69: 883889.
  • Zhong H, Belardinelli L, Maa T, Feoktisto I, Biaggioni I, Zeng D (2004). A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 30: 118125.
  • Zhong H, Belardinelli L, Maa T, Zeng D (2005). Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts. Am J Respir Cell Mol Biol 32: 28.
  • Zhong H, Chunn JL, Volmer JB, Fozard JR, Blackburn MR (2001). Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice. J Pharmacol Exp Ther 298: 433440.
  • Zhong H, Wu Y, Belardinelli L, Zeng D (2006). A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase. Am J Respir Cell Mol Biol 35: 587592.